We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urinary Eosinophils Commonly Found After Bladder Surgery

By LabMedica International staff writers
Posted on 23 Nov 2011
Print article
Urine samples are examined for the presence of eosinophils, which are used to screen for acute interstitial nephritis (AIN).

Patients with urinary diversion surgeries such as ileal conduit surgery, frequently have an unusually high number of urinary eosinophils, a specific kind of white cell.

At the Mayo Clinic (Rochester, MN, USA) technologists examined urine samples from three cohorts with 20 patients in each group. In the first group, urinalysis samples were with a “stoma” source indicating a previous ileal conduit surgery; in the second group the urine samples had been clinically submitted for eosinophil quantification; and for the third cohort, randomly selected urinalysis samples was performed where there was with a minimum of 1-3 leucocytes per high-powered field. Urinary eosinophils were quantified after Hansel staining as the mean of independent counts by four technologists who did not know the source. Hansel stain is used to detect eosinophils in urine or other body fluids, the eosinophils staining red against a background of blue.

In the stoma group, eosinophils composed an average 19% of the urinary white cells even though none had a clinical suspicion of AIN. In contrast, only 3.5% and 4.6% of the urinary leucocytes were eosinophils among patients with clinically ordered eosinophiluria testing and in a random sample of patients with pyuria, respectively. Importantly, 18 out of 20 (90%) of the stoma patients had greater than 5% eosinophils, meeting the criterion for a positive test.

The authors concluded that patients with a previous ileal conduit surgery have markedly elevated urinary eosinophils, far in excess of typical patients with pyuria or those with clinically ordered eosinophiluria testing. Therefore, urinary eosinophils are not a useful screen for AIN in patients after ileal conduit surgery. Acute interstitial nephritis is an immunologic adverse reaction to certain drugs, often sulfonamide or methicillin. Acute renal failure, fever, rash, and proteinuria are characteristic of this condition. The study was published in the November 2011 edition of the journal Clinical Chemistry and Laboratory Medicine.

Related Links:

Mayo Clinic



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
New
Ultrasonic Cleaner
UC 300 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.